QBTS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds D-Wave Quantum Investors of Securities Class Action Lawsuit Deadline on December 15, 2026

Faruqi & Faruqi is investigating potential claims against D-Wave Quantum in connection with a federal securities class action. Investors who acquired securities from February 26 through August 25, 2026, are reminded of the December 15, 2026 deadline to seek lead-plaintiff status; the notice does not specify the allegations or any financial impact.

Analysis

This is a legal-overhang signal, not evidence that the allegations are valid or that operating results have changed. For QBTS, the market channel is likely a higher uncertainty discount: investors may demand more evidence before underwriting long-dated commercialization, and any equity financing or customer/partner diligence could become more sensitive to disclosure credibility. Those effects are conditional; the article provides no alleged conduct, loss estimate, insurance information, or operational impact to quantify them.

Near term, expect headline-driven volatility around the complaint and lead-plaintiff process, with limited basis to infer a durable earnings revision. Over 1–3 months, the useful catalysts are the complaint’s specific allegations, the company’s response, and court rulings on pleadings—not the law firm’s investor solicitation. Over 6–18 months, the material question is whether litigation creates meaningful cash expense, management distraction, governance changes, or impaired access to capital; none is established here.

Contrarian read: the notice may prompt reflexive selling despite containing no new merits finding. Conversely, treating the matter as immaterial before reviewing the actual complaint would underprice disclosure and financing risk. No directional position is justified from this item alone; reassess if filings identify specific alleged misstatements tied to prior guidance or if the company signals a material financial or governance consequence. Dismissal or narrowing of claims without operational implications would weaken the overhang thesis.

Key Decisions for Investors

• Do not initiate a standalone short or buy puts on this notice alone; there is no quantified damages, merits finding, or demonstrated earnings impact, and event volatility can make options unattractive.
• For existing QBTS exposure, review the filed complaint and subsequent company disclosures before adding; track any linkage between alleged statements and commercialization, bookings, cash runway, or financing plans.
• Set a litigation watch through the December 15 lead-plaintiff deadline and subsequent pleadings. Escalate risk assessment if the complaint identifies specific disputed disclosures or the company flags material legal expense, governance changes, or capital-access effects.
• Falsification/relief indicators: dismissal or substantial narrowing of claims, no material updates to financial guidance, and no evidence of operational or financing consequences. A court finding that permits central disclosure claims to proceed would strengthen the overhang, but would not by itself establish liability.